
Health Studies Hub
Your go-to source for daily breakdowns of the latest health, fitness, and nutrition research.
Poor Sleep Drives Unhealthy Eating Choices.
In 2025, Andrea Bazzani and Ugo Faraguna from Italian universities wrote an editorial reviewing how eating and sleeping are linked. They looked at past studies showing poor sleep changes what we crave, like more sweets and high-calorie foods, due to hormone shifts like less leptin (fullness signal) and more ghrelin (hunger signal). This can lead to overeating and weight gain.
Artificial Sweeteners Speed Up Brain Aging by 1.6 Years
In 2025, Claudia Kimie Suemoto and a team from the University of São Paulo in Brazil studied 12,772 middle-aged adults (average age 52) over several years. They tracked intake of seven sweeteners like aspartame and saccharin in ultra-processed foods such as diet sodas and yogurts, using food surveys and cognitive tests for memory and thinking skills.
Creatine Plus Exercise Prevents Type 2 Diabetes.
In 2025, Ewelina Młynarska and a team from the Medical University of Lodz reviewed studies on creatine monohydrate supplementation combined with exercise for preventing type 2 diabetes. They focused on how skeletal muscle, which handles most body glucose, loses function in type 2 diabetes due to insulin resistance and sarcopenia (muscle wasting), and how creatine monohydrate—found in meat/fish or supplements—might help alongside workouts like weights or aerobics.
7,000 Steps Daily Boost Health, Slash Disease Risk.
In 2025, Melody Ding and a team from The University of Sydney reviewed 35 studies with over 16,000 adults from 2014-2025. They analyzed how daily step counts affect eight health outcomes, including heart disease, type 2 diabetes, dementia, cancer, depression, falls, physical function, and overall death risk, using data from PubMed and EBSCO CINAHL.
French Fries Raise Type 2 Diabetes Risk by 20%.
In 2025, Seyed Mohammad Mousavi and team from Harvard T.H. Chan School of Public Health analyzed data from three large US studies with over 205,000 health professionals followed for nearly 40 years. They tracked potato intake—French fries vs. boiled, baked, or mashed—and diabetes cases, adjusting for lifestyle factors like smoking and exercise. 22,299 people developed type 2 diabetes during the study.
Ultraprocessed Foods Significantly Raise Heart Disease Risks.
In 2025, Maya K. Vadiveloo and a team from the American Heart Association reviewed studies on ultraprocessed foods like chips, sodas, and ready meals. They looked at how these foods, often high in fats, sugars, and salt, affect health in the US where 55% of calories come from them, rising to 62% in youth.
Gallbladder Removal Increases Fatty Liver Disease Risk.
In 2025, HJ Jeon and team from South Korea studied 661,122 people using the Korean National Health Insurance Service data. They compared 4,664 patients who had their gallbladder removed to 13,992 matched individuals who didn’t, over 5.35 years, to check for metabolic dysfunction-associated steatotic liver disease (MASLD), a fatty liver condition tied to obesity or diabetes.
How Diet Fuels Fat-Burning Tissues for Better Health.
In 2025, Bruna Bombassaro and team from the University of Campinas reviewed how dietary factors like caffeine, capsaicin, cinnamon, curcumin, resveratrol, and fatty acids (EPA, DHA, oleic acid) activate brown and beige adipose tissues (BAT) to burn calories via thermogenesis.
Ultra-Processed Foods Worsen Depression-Diabetes Link.
In 2025, Yunxiang Sun and team from Johns Hopkins and Brazilian universities analyzed survey data from over 87,000 adults in Brazil. They used self-reports on diabetes, depression, and diet (via food frequency questionnaires) to check how ultra-processed food (UPF) intake affects the depression-diabetes connection, running stats adjusted for age, income, and more.
Just Two Workouts a Week Cut Heart Death Risk in Diabetics.
In 2025, a study from AnnalsofIM and others tracked 50,000+ adults with diabetes over years, using health records to compare exercise habits. They grouped people as inactive, insufficiently active, weekend warriors (≥150 min/week in 1–2 sessions), or regularly active, measuring heart-related deaths and overall mortality.
Fasting Twice a Week Helps Type 2 Diabetes Control.
In 2025, Haohao Zhang and team at Zhengzhou University compared three diets for 52 obese people with type 2 diabetes: intermittent fasting (5:2 plan, eating normally five days and cutting calories two), time-restricted eating, and steady calorie reduction. They measured weight, blood sugar, and insulin response over months.
“We Are Not Over Fat, We Are Under Muscled.”
This statement by Dr. Gabrielle Lyon isn’t just catchy—it’s scientifically sound. A 2024 Scientific Reports study analyzing nearly 11,000 adults found that a high lean mass to visceral fat ratio was tied to up to 88% lower risk of type 2 diabetes and significantly fewer cases of high blood pressure and abnormal cholesterol levels.
Sugar Is the World’s #3 Calorie Source And It’s Slowly Killing Us.
Globally, added sugar now makes up around 10% of total calories consumed, ranking just behind grains and produce. But while those provide some nourishment, sugar contributes little and harms much. A 2023 Annual Review study warns that sugar—not fat—is driving the chronic disease epidemic. And sugar-sweetened beverages (SSBs) are the worst offenders.
Selenium May Protect Against Cancer, Diabetes, and Aging.
A 2025 review in Nutrients by Zhang dives into the crucial roles selenium plays in our bodies. As a key part of selenoproteins, this micronutrient helps balance redox reactions, regulate cell growth, support the immune system, and guard against DNA damage, chronic inflammation, insulin resistance, and neurodegeneration.
Curcumin Can Help Lower Blood Sugar in Just 12 Weeks.
A 2025 double-blind, placebo-controlled trial by Lamichhane et al. in Nutrients found that elderly prediabetic adults taking 80 mg/day of curcumin for 12 weeks saw significant reductions in HbA1c, a key marker of long-term blood sugar control.
A Diabetes Drug Just Cut Migraines in Half—Here’s How.
A 2025 pilot study from the University of Naples “Federico II” found that the diabetes drug liraglutide (a GLP-1 receptor agonist) reduced monthly migraine days by over 50% in patients with chronic migraine.